Usana health sciences, inc. (USNA)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities
Net earnings

100,526

126,224

62,535

100,041

94,672

76,636

79,024

66,433

50,752

45,651

33,556

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization

14,743

16,843

16,110

13,482

9,978

8,810

9,044

8,826

8,474

7,916

7,069

Right-of-use asset amortization

8,264

-

-

-

-

-

-

-

-

-

-

(Gain) loss on sale of property and equipment

-84

-1,805

-18

-116

-3

-46

16

36

-45

-94

149

Equity-based compensation expense

15,541

14,955

15,482

16,542

11,081

9,805

7,624

10,210

10,549

10,406

8,925

Excess tax benefits from equity-based payment arrangements

-

-

-

-

12,024

14,834

7,466

3,443

48

2,449

11

Common stock awarded to Associates

-

-

-

-

-

-

-

80

-

-

-

Deferred income taxes

-3,635

699

19,306

-3,700

-2,572

-1,039

814

4,111

-1,599

3,194

-2,296

(Gain) loss on impairment on note receivable

-

-658

2,734

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Inventories

-12,990

23,101

-6,054

1,034

23,071

-1,102

11,783

-1,370

3,209

4,982

299

Prepaid expenses and other assets

-7,189

1,626

-5,010

9,749

2,047

3,789

8,465

6,341

-4,024

5,218

-1,685

Income tax payable related to tax benefit from equity award activity

-

-

-

-

12,024

14,712

7,075

1,827

-

-

-

Accounts payable

1,835

-1,720

3,043

-1,341

2,481

-1,337

2,790

-985

1,502

-1,981

-1,138

Other liabilities

-30,804

18,698

-6,518

22,534

20,941

15,073

20,252

10,753

-382

13,477

-14,873

Total adjustments

-

-

-

-

-

-

-

-

-

20,457

-1,087

Net cash provided by (used in) operating activities

126,733

152,119

123,774

136,891

111,466

105,185

98,893

92,805

70,108

66,108

32,469

Cash flows from investing activities
Additions to notes receivable

-

-

-

7

1,580

4,495

4,942

-

-

-

151

Receipts on notes receivable

231

4,849

296

811

-

-

-

-

-

-

245

Proceeds from the settlement of net investment hedges

1,936

739

-

-

-

-

-

-

-

-

-

Payments for net investment hedge

1,660

-

-

-

-

-

-

-

-

-

-

Purchases of investment securities held-to-maturity

-

86,396

-

-

-

3,871

8,643

-

-

-

-

Maturities of investment securities held-to-maturity

63,539

22,857

-

-

-

12,511

-

-

-

-

-

Acquisitions, net of cash acquired

-

-

-

-

-

-

-

-

-

42,694

-

Proceeds from sale of property and equipment

17

381

22

11

185

10

47

154

34

33

837

Purchases of property and equipment

16,569

11,433

13,220

32,698

23,729

20,421

8,051

8,432

10,643

4,192

4,128

Net cash provided by (used in) investing activities

47,494

-69,003

-12,902

-31,883

-25,124

-16,266

-21,589

-8,278

-10,609

-46,853

-3,197

Cash flows from financing activities
Proceeds from equity awards exercised

-

-

-

-

-

10,970

454

309

39

12,005

131

Excess tax benefits from equity-based payment arrangements

-

-

-

-

12,024

14,834

7,466

3,443

48

2,449

11

Repurchase of common stock

150,000

105,375

50,000

64,610

61,181

138,819

18,085

68,294

33,459

17,031

1,654

Proceeds from disgorgement of short-swing stock profits

-

907

-

-

-

-

-

-

-

-

-

Borrowings on line of credit

5,000

-

3,500

73,700

-

30,000

-

1,846

-

31,150

57,020

Payments on line of credit

5,000

-

3,500

73,700

-

30,000

-

1,846

-

38,150

85,010

Payments related to tax withholding for net-share settled equity awards

1,987

809

316

-

-

-

-

-

-

-

-

Payments for debt issuance costs

65

-

-

250

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-152,052

-105,277

-50,316

-64,860

-49,157

-113,015

-10,165

-64,542

-33,372

-9,577

-29,502

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-1,721

-11,140

11,027

-7,929

-5,101

-2,121

-635

501

4

886

607

Net increase (decrease) in cash, cash equivalents and restricted cash

20,454

-33,301

71,583

32,219

32,084

-26,217

66,504

20,486

26,131

10,564

377

Cash paid during the period for:
Interest

11

6

16

323

15

136

1

20

10

99

552

Income taxes

54,914

70,683

46,006

52,579

35,782

26,955

26,952

27,131

24,539

21,628

22,817

Cash received during the period for:
Income tax refund

5,542

2,698

4,700

-

-

-

-

-

-

-

-

Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations

33,258

-

-

-

-

-

-

-

-

-

-

Credits on notes receivable

-

-

86

1,288

966

720

198

-

-

-

-

Accrued purchases of property and equipment

998

195

109

2,216

6,863

1,805

-

-

-

-

-

Common stock issued in connection with acquisitions

-

-

-

-

-

-

-

-

-

17,716

-